AKTS

NASDAQStock

Aktis Oncology, Inc.

$18.84+0.55 (+3.01%)

52-Week Range

$17.63

$22.40

Key Stats

Market Cap

989.5M

P/E Ratio

—

Dividend Yield

—

Beta

0.00

Volume

240.3K

Avg Volume

208.4K

Performance

+2.98%

-18.35%

YTD

-18.35%

+471.56%

+36.39%

Price Chart

ETF Exposure

AKTS is held by 13 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
TENG	Direxion Daily 5G Communications Bull 2X Shares	0.17%	830	$3K	$712K	0.95%
BMED	iShares Health Innovation Active ETF	0.11%	597	$12K	$10.6M	0.77%
VTWG	Vanguard Russell 2000 Growth ETF	0.00%	385	$8K	$1.50B	0.06%
VTWO	Vanguard Russell 2000 ETF	0.00%	3,954	$80K	$14.50B	0.06%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	0	$21	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	28	$777	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$3	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	70	$1K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	16,135	$327K	$2.10T	0.03%
VTWV	Vanguard Russell 2000 Value ETF	0.00%	125	$3K	$1.00B	0.06%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	84	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	7	$200	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	5,211	$106K	$84.10B	0.05%

About AKTS ETF Exposure

Aktis Oncology, Inc. (AKTS) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 989.5M, AKTS is a widely held institutional stock. The stock currently trades at $18.84. Investors can gain exposure to AKTS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AKTS, sorted by portfolio weight.